{"id":"https://openalex.org/W4388047666","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0573","title":"573 BTN1A1-Targeted Immunotherapy Combined with Standard Therapy in Small Cell Lung Cancer (SCLC) and Colorectal Cancer","display_name":"573 BTN1A1-Targeted Immunotherapy Combined with Standard Therapy in Small Cell Lung Cancer (SCLC) and Colorectal Cancer","publication_year":2023,"publication_date":"2023-10-31","ids":{"openalex":"https://openalex.org/W4388047666","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0573"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0573","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0573","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0573","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/650.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/650.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086706998","display_name":"Stephen Sunghan Yoo","orcid":"https://orcid.org/0000-0002-3730-3828","observed_orcids":["https://orcid.org/0000-0002-3730-3828"]},"institutions":[{"id":"https://openalex.org/I4210090831","display_name":"STCube (United States)","ror":"https://ror.org/00bv2aa44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090831"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen S Yoo","raw_affiliation_strings":["STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210090831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100757543","display_name":"Soo Hyun Lee","orcid":"https://orcid.org/0000-0001-9665-062X","observed_orcids":["https://orcid.org/0000-0001-9665-062X"]},"institutions":[{"id":"https://openalex.org/I4210090831","display_name":"STCube (United States)","ror":"https://ror.org/00bv2aa44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090831"]},{"id":"https://openalex.org/I4405260934","display_name":"Korea University Anam Hospital","ror":"https://ror.org/04gjj3027","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I197347611","https://openalex.org/I2799980853","https://openalex.org/I4405260934"]}],"countries":["KR","US"],"is_corresponding":false,"raw_author_name":"Soohyeon Lee","raw_affiliation_strings":["Korea University Anam Hospital, Seoul, Republic of Korea","STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Korea University Anam Hospital, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I4405260934"]},{"raw_affiliation_string":"STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210090831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100399223","display_name":"Seung\u2010Hoon Lee","orcid":"https://orcid.org/0000-0001-8614-8345","observed_orcids":["https://orcid.org/0000-0001-8614-8345"]},"institutions":[{"id":"https://openalex.org/I4210090831","display_name":"STCube (United States)","ror":"https://ror.org/00bv2aa44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090831"]},{"id":"https://openalex.org/I4405260934","display_name":"Korea University Anam Hospital","ror":"https://ror.org/04gjj3027","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I197347611","https://openalex.org/I2799980853","https://openalex.org/I4405260934"]}],"countries":["KR","US"],"is_corresponding":false,"raw_author_name":"Seung-Hoon Lee","raw_affiliation_strings":["Korea University Anam Hospital, Seoul, Republic of Korea","STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Korea University Anam Hospital, Seoul, Republic of Korea","institution_ids":["https://openalex.org/I4405260934"]},{"raw_affiliation_string":"STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210090831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065754233","display_name":"Young Seung Kim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090831","display_name":"STCube (United States)","ror":"https://ror.org/00bv2aa44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090831"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Young Seung Kim","raw_affiliation_strings":["STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210090831"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068926590","display_name":"Chunai Wu","orcid":"https://orcid.org/0009-0007-1237-0841","observed_orcids":["https://orcid.org/0009-0007-1237-0841"]},"institutions":[{"id":"https://openalex.org/I4210090831","display_name":"STCube (United States)","ror":"https://ror.org/00bv2aa44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090831"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chunai Wu","raw_affiliation_strings":["STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210090831"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080372953","display_name":"Andrew H Park","orcid":"https://orcid.org/0009-0001-6787-324X","observed_orcids":["https://orcid.org/0009-0001-6787-324X"]},"institutions":[{"id":"https://openalex.org/I4210090831","display_name":"STCube (United States)","ror":"https://ror.org/00bv2aa44","country_code":"US","type":"company","lineage":["https://openalex.org/I4210090831"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew H Park","raw_affiliation_strings":["STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"STCube Pharmaceuticals, Inc, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210090831"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A650","last_page":"A650"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/btn1a1","display_name":"BTN1A1","score":0.9879999756813049},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.7799999713897705},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9990000128746033},{"id":"https://openalex.org/keywords/immune-checkpoint","display_name":"immune checkpoint","score":0.699999988079071},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.75},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.6100000143051147},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.7369999885559082},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.7360000014305115},{"id":"https://openalex.org/keywords/innate-immune-response","display_name":"innate immune response","score":0.6650000214576721},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5479999780654907},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.335999995470047},{"id":"https://openalex.org/keywords/chemotherapy-synergy","display_name":"chemotherapy synergy","score":0.6700000166893005},{"id":"https://openalex.org/keywords/tumor-organoids","display_name":"tumor organoids","score":0.5339999794960022},{"id":"https://openalex.org/keywords/zebrafish-tumor-model","display_name":"zebrafish tumor model","score":0.7979999780654907}],"concepts":[{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6297765970230103},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5404819250106812},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5372258424758911},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.5208662152290344},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.509994387626648},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.49633103609085083},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.47155094146728516},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.46820881962776184},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4520528018474579},{"id":"https://openalex.org/C2778608917","wikidata":"https://www.wikidata.org/wiki/Q6787805","display_name":"Matrigel","level":3,"score":0.4460163116455078},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.42825794219970703},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.4049971103668213},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3644574284553528},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27091681957244873},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1928742229938507},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.16432583332061768}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2023-sitc2023.0573","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0573","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0573","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/650.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:bbf912e6211a4faebd3d86d0a12c7eb9","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/bbf912e6211a4faebd3d86d0a12c7eb9","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2023-sitc2023.0573","doi":"https://doi.org/10.1136/jitc-2023-sitc2023.0573","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2023-sitc2023.0573","pdf_url":"https://jitc.bmj.com/content/jitc/11/Suppl_1/650.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4388047666.pdf","grobid_xml":"https://content.openalex.org/works/W4388047666.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4404065582","https://openalex.org/W4415942909","https://openalex.org/W4415898995","https://openalex.org/W4394761860","https://openalex.org/W4388045551","https://openalex.org/W3178806844","https://openalex.org/W4404052819","https://openalex.org/W4282932321","https://openalex.org/W4308384321","https://openalex.org/W4393090941"],"abstract_inverted_index":{"Background":[0],"Butyrophilin":[1],"1A1":[2],"(BTN1A1)":[3],"has":[4],"been":[5],"identified":[6],"as":[7,107,268,270],"a":[8,75,187,253,378],"novel":[9,379],"immune":[10,119,214,236,262,360,380],"checkpoint":[11,381],"protein":[12],"that":[13,26,60,303,351,375,382],"could":[14,63],"potentially":[15],"be":[16,47,384],"targeted":[17,385],"to":[18,46,71,111,210,234,252,338,386,389],"create":[19],"new":[20],"immunotherapeutic":[21],"treatment":[22,166,353],"options.":[23],"We":[24,89],"observed":[25],"BTN1A1":[27,39,62,244,328,376],"and":[28,40,53,104,121,130,144,164,172,203,213,227,273,280,291,295,309,315,347,363],"PD-L1":[29,41],"expression":[30,42,326],"are":[31],"mutually":[32],"exclusive":[33],"in":[34,152,232,247,318,329,345,355,392],"various":[35],"human":[36],"solid":[37],"tumors.":[38],"levels":[43],"were":[44,128,150,156,177,193,208,230],"found":[45,324],"negatively":[48],"correlated":[49],"across":[50],"cell":[51,126,249],"lines":[52,127,250],"tumor":[54,92,274,320],"samples":[55],"from":[56,332],"patients.":[57,394],"This":[58],"suggests":[59],"targeting":[61],"benefit":[64],"patients":[65],"whose":[66],"tumors":[67,331],"do":[68],"not":[69],"respond":[70],"anti-PD-1/PD-L1":[72],"therapy.":[73,297,371],"Recently,":[74],"phase":[76],"1":[77],"clinical":[78,348],"trial":[79],"of":[80,115,135,186,225,238,243,256,289,311,327,358],"hSTC810,":[81,143,163],"an":[82],"antibody":[83,198],"against":[84,199],"BTN1A1,":[85],"was":[86],"successfully":[87],"completed.":[88],"characterized":[90],"patient":[91],"biopsy":[93],"slides":[94],"based":[95],"on":[96],"BTN1A1/PD-L1":[97],"expression.":[98],"Additionally,":[99,322],"we":[100,323],"used":[101],"zebrafish,":[102,278],"organoid,":[103,279],"mouse":[105,200,281],"models":[106],"multiple":[108],"evaluation":[109],"platforms":[110],"understand":[112],"the":[113,133,169,183,235,239,260,265,277,286,307,319,325,356],"heterogeneity":[114],"interaction":[116],"mechanisms":[117],"between":[118],"cells":[120,176,215,314,317],"cancer":[122,148,212,248,340],"cells.":[123,341],"Methods":[124],"NCI-H345":[125],"labeled":[129],"injected":[131,194],"into":[132,182],"pericardium":[134],"zebrafish":[136],"larvae":[137],"(2":[138],"dpf)":[139],"along":[140],"with":[141,195,259,293,369],"hPBMC,":[142,162],"5-FU.":[145,204],"Patient-derived":[146],"lung":[147],"organoids":[149,155],"grown":[151],"Matrigel.":[153],"The":[154],"examined":[157],"for":[158],"morphologic":[159],"disruption":[160],"following":[161],"Paclitaxel":[165],"by":[167,179,245],"assessing":[168],"organoid":[170],"size":[171],"formation":[173],"rate.":[174],"MC38":[175],"allografted":[178],"subcutaneously":[180],"implanting":[181],"right":[184],"flank":[185],"mouse.":[188],"After":[189],"10":[190],"days,":[191],"mice":[192],"STC109":[196],"(an":[197],"BTN1A1),":[201],"anti-PD-L1,":[202],"Patients\u2018":[205],"FFPE":[206],"specimens":[207],"stained":[209],"identify":[211],"using":[216],"Opal":[217,298],"multiplex":[218,299],"immunofluorescence.":[219],"In":[220,276,343],"every":[221],"experiment,":[222],"synergistic":[223],"effects":[224],"anti-BTN1A1":[226,283,304],"other":[228],"therapies":[229,391],"analyzed":[231],"relation":[233],"context":[237],"tumor.":[240],"Results":[241],"Inhibition":[242],"hSTC810":[246,352],"leads":[251],"prominent":[254],"upregulation":[255],"genes":[257],"associated":[258],"innate":[261,359],"response,":[263],"including":[264],"JAK-STAT":[266],"pathway,":[267],"well":[269],"T-cell":[271],"activation":[272,310,357],"clearance.":[275],"models,":[282],"therapy":[284,305],"enhanced":[285],"anti-tumor":[287,365],"activity":[288,366],"hPBMC":[290],"synergized":[292],"chemotherapy":[294],"anti-PD-L1":[296,370],"immunofluorescence":[300],"analysis":[301],"revealed":[302],"increased":[306],"infiltration":[308],"CD8+":[312],"T":[313],"NK":[316],"microenvironment.":[321],"Ki67-negative":[330],"SCLC":[333,393],"patients,":[334],"which":[335],"is":[336,377],"opposite":[337],"PD-L1-expressing":[339],"Conclusions":[342],"vitro,":[344],"vivo,":[346],"data":[349],"show":[350],"results":[354,373],"response":[361],"pathways":[362],"enhances":[364],"when":[367],"combined":[368],"Our":[372],"suggest":[374],"can":[383],"overcome":[387],"resistance":[388],"conventional":[390]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2023-11-01T00:00:00"}